Inj.

Renamic Vet

Drug Class: Antihemorrhagics

Manufacturer: Renata Pharmaceuticals Ltd.

Basic information

Generic Drug

Route of Administration

IM/IV/SC

Strength / Concentration

100 mg/ml

Presentation and price

10 ml vial

50 Taka

30 ml vial

130 Taka

Dose and dosage

Buffalo

1ml/4-20kg body weight once/twice a day. If necessary repeat every 8 hours.

For external use: Should be applied with cotton as required.

Horse

1ml/4-20kg body weight once/twice a day. If necessary repeat every 8 hours.

For external use: Should be applied with cotton as required.

Swine

1ml/7-10kg body weight once/twice a day. If necessary repeat every 8 hours.

For external use: Should be applied with cotton as required.

Dog

1ml/7-10kg body weight once/twice a day. If necessary repeat every 8 hours.

For external use: Should be applied with cotton as required.

Cat

1ml/7-10kg body weight once/twice a day. If necessary repeat every 8 hours.

For external use: Should be applied with cotton as required.

Sheep

1ml/10kg body weight once/twice a day. If necessary repeat every 8 hours.

For external use: Should be applied with cotton as required.

Goat

1ml/10kg body weight once/twice a day. If necessary repeat every 8 hours.

For external use: Should be applied with cotton as required.

Cattle

1ml/4-20kg body weight once/twice a day. If necessary repeat every 8 hours.

For external use: Should be applied with cotton as required.


Applications: Surgical Bleeding, Accidental Bleeding, Nasal Bleeding, Rectal Bleeding, Uterine Bleeding, Bleeding during or before parturition, Hematuria, Bleeding due different disease conditions
-----

Tranexamic acid can be used in any hemorrhagic condition of animals

Tranexamic acid competitively and reversibly inhibits the activation of plasminogen via binding at several distinct sites, including four or five low-affinity sites and one high-affinity site, the latter of which is involved in its binding to fibrin. The binding of plasminogen to fibrin induces fibrinolysis - by occupying the necessary binding sites tranexamic acid prevents this dissolution of fibrin, thereby stabilizing the clot and preventing hemorrhage.

Albutrepenonacog alfa : Tranexamic acid may increase the thrombogenic activities of Albutrepenonacog alfa.
Alpha-1-proteinase inhibitor : Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Tranexamic acid.
Alteplase : The therapeutic efficacy of Tranexamic acid can be decreased when used in combination with Alteplase.
Aminocaproic acid: Tranexamic acid may increase the thrombogenic activities of Aminocaproic acid.
Andexanet alfa: Tranexamic acid may increase the thrombogenic activities of Andexanet alfa

Meat: 2days.

Milk: 2 days